Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) shares gained by 2.04%

759

Dallas, Texas 07/10/2013 (Financialstrend) – The shares of Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) are currently trading at $4.50, shares increased by 2.04%. The 52-week high price is $7.44 and the 52-week low price stood at $2.98. With 90.18 million total outstanding shares, the market capitalization of Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) is $397.70 million. The intraday share trading volume for yesterday was 1.40 million, whereas the average trading volume heads up to 852,272 shares. Institutional owners record a contribution of 17 percent of the total outstanding shares.

Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) is concentrated on the development of drugs to cure diseases and disorders related to gastrointestinal problems.  For the treatment of chronic constipation and constipation-predominant-irritable bowel syndrome, the company developed its lead product candidate – the receptor agonist, plecanatide, a guanylyl cyclase.  For the treatment of gastrointestinal inflammatory diseases, the ulcerative colitis SP-333 and GC-C receptors are used. Third party contractors manufacture the formulated drug products and active pharmaceutical ingredients.  A synthetic hexadecapeptide has been developed by the company for the treatment of CC and IBS-C plecanatide. GC-C receptor is used as agonist for Plecanatide.

Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) was assigned ‘buy’ ratings based on the company’s constipation drug candidate Plecanatide. The company’s chairman disclosed that the company will buy back more shares, leading to a further boost of its stock price. The company’s most advanced drug is Plecanatide, for the treatment of chronic constipation; the company also develops SP-333 for the treatment of ulcerative colitis. The company sold 16.4 million shares and raised $84.4 million after discounts, commissions and expenses in April 2013.

Subscribe to get your free report!

* indicates required
*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.